Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer

Luca Giraldi; Giulia Collatuzzo; Dana Hashim; Silvia Franceschi; Rolando Herrero; Chu Chen; Stephen M. Schwartz; Elaine Smith; Karl Kelsey; Michael McClean; Maura Gillison; Stefania Boccia; Mia Hashibe; Yuan Chin Amy Lee; Paolo Boffetta

doi:10.1016/j.canep.2021.102020

Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer

Luca Giraldi, Giulia Collatuzzo, Dana Hashim, Silvia Franceschi, Rolando Herrero, Chu Chen, Stephen M. Schwartz, Elaine Smith, Karl Kelsey, Michael McClean, Maura Gillison, Stefania Boccia, Mia Hashibe, Yuan Chin Amy Lee, Paolo Boffetta

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Background: The aim of this study was to investigate the relationship between high-risk genotypes of Human Papilloma Virus (HPV) and cancer of different subsites of the oral cavity. Material and methods: A pooled analysis of five studies included on the International Head and Neck Cancer Epidemiology (INHANCE) Consortium was conducted. HPV 16 and HPV 18 were considered. Adjusted odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for HPV and each oral cavity subsites were simultaneously estimated using multinomial logistic regression models. Results: The analysis included 1157 cases and 3272 controls. This study showed a slightly higher prevalence of HPV infection among oral cancer cases than controls. In particular, an increased risk of other and not otherwise specified (NOS) sites within the oral cavity, oral tongue, palate and floor of mouth cancer was observed for overall HPV16 positivity (OR = 1.66, 95 % CI: 1.01−2.72; OR = 1.97, 95 % CI: 1.36−2.85; OR = 2.48, 95 % CI: 1.50−4.11; OR = 2.71, 95 % CI: 1.06−6.95, respectively). In particular, HPV16E7 was related to cancer of floor of mouth, oral cavity NOS and palate (OR = 2.71, 95 % CI: 1.06−6.95; OR = 3.32, 95 % CI:1.53−7.19; OR = 3.34, 95 % CI:1.38−8.06). Results were inconsistent for HPV18 due to low prevalence of infection. Conclusion: Our study suggests that HPV16 infection may increase the risk of developing floor of mouth, gum, tongue, and palate cancers. Clinical relevance: Subjects with HPV infection have a higher risk of cancer from all sites of the oral cavity.

Original language	English (US)
Article number	102020
Journal	Cancer Epidemiology
Volume	75
DOIs	https://doi.org/10.1016/j.canep.2021.102020
State	Published - Dec 2021

Keywords

Floor of mouth
Gum
Human papilloma virus
Oral cancer
Oral cavity
Palate
Tongue

ASJC Scopus subject areas

Epidemiology
Oncology
Cancer Research

Access to Document

10.1016/j.canep.2021.102020

Cite this

Giraldi, L., Collatuzzo, G., Hashim, D., Franceschi, S., Herrero, R., Chen, C., Schwartz, S. M., Smith, E., Kelsey, K., McClean, M., Gillison, M., Boccia, S., Hashibe, M., Amy Lee, Y. C., & Boffetta, P. (2021). Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiology, 75, Article 102020. https://doi.org/10.1016/j.canep.2021.102020

@article{4cc1fb3817624ecbb228a1e889c7a031,

title = "Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer",

abstract = "Background: The aim of this study was to investigate the relationship between high-risk genotypes of Human Papilloma Virus (HPV) and cancer of different subsites of the oral cavity. Material and methods: A pooled analysis of five studies included on the International Head and Neck Cancer Epidemiology (INHANCE) Consortium was conducted. HPV 16 and HPV 18 were considered. Adjusted odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for HPV and each oral cavity subsites were simultaneously estimated using multinomial logistic regression models. Results: The analysis included 1157 cases and 3272 controls. This study showed a slightly higher prevalence of HPV infection among oral cancer cases than controls. In particular, an increased risk of other and not otherwise specified (NOS) sites within the oral cavity, oral tongue, palate and floor of mouth cancer was observed for overall HPV16 positivity (OR = 1.66, 95 % CI: 1.01−2.72; OR = 1.97, 95 % CI: 1.36−2.85; OR = 2.48, 95 % CI: 1.50−4.11; OR = 2.71, 95 % CI: 1.06−6.95, respectively). In particular, HPV16E7 was related to cancer of floor of mouth, oral cavity NOS and palate (OR = 2.71, 95 % CI: 1.06−6.95; OR = 3.32, 95 % CI:1.53−7.19; OR = 3.34, 95 % CI:1.38−8.06). Results were inconsistent for HPV18 due to low prevalence of infection. Conclusion: Our study suggests that HPV16 infection may increase the risk of developing floor of mouth, gum, tongue, and palate cancers. Clinical relevance: Subjects with HPV infection have a higher risk of cancer from all sites of the oral cavity.",

keywords = "Floor of mouth, Gum, Human papilloma virus, Oral cancer, Oral cavity, Palate, Tongue",

author = "Luca Giraldi and Giulia Collatuzzo and Dana Hashim and Silvia Franceschi and Rolando Herrero and Chu Chen and Schwartz, {Stephen M.} and Elaine Smith and Karl Kelsey and Michael McClean and Maura Gillison and Stefania Boccia and Mia Hashibe and {Amy Lee}, {Yuan Chin} and Paolo Boffetta",

note = "Funding Information: The pooled data coordination team were supported by National Cancer Institute grant R03CA113157and by National Institute of Dental and Craniofacial Research grantR03DE016611. The IARC Multicenter study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [FIS 97/ 0024, FIS 97/0662, BAE 01/5013], International Union Against Cancer (UICC), and Yamagiwa-Yoshida Memorial International Cancer Study Grant. The Seattle study was funded by NIH [R01CA048996,R01DE012609]. The Iowa study was funded by NIH [NIDCRR01DE011979, NIDCRR01DE013110, NIH FIRCATW001500] and Veterans Affairs Merit Review Funds. The Boston study was funded by NIH [R01CA078609, R01CA100679]. The Baltimore study was funded by NIH [DE016631]. Funding Information: The pooled data coordination team were supported by National Cancer Institute grant R03CA113157 and by National Institute of Dental and Craniofacial Research grant R03DE016611 . The IARC Multicenter study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [ FIS 97/ 0024 , FIS 97/0662 , BAE 01/5013 ], International Union Against Cancer (UICC) , and Yamagiwa-Yoshida Memorial International Cancer Study Grant. The Seattle study was funded by NIH [ R01CA048996 , R01DE012609 ]. The Iowa study was funded by NIH [NIDCR R01DE011979, NIDCR R01DE013110 , NIH FIRCA TW001500 ] and Veterans Affairs Merit Review Funds . The Boston study was funded by NIH [ R01CA078609 , R01CA100679 ]. The Baltimore study was funded by NIH [ DE016631 ]. Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",

year = "2021",

month = dec,

doi = "10.1016/j.canep.2021.102020",

language = "English (US)",

volume = "75",

journal = "Cancer Epidemiology",

issn = "1877-7821",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer

AU - Giraldi, Luca

AU - Collatuzzo, Giulia

AU - Hashim, Dana

AU - Franceschi, Silvia

AU - Herrero, Rolando

AU - Chen, Chu

AU - Schwartz, Stephen M.

AU - Smith, Elaine

AU - Kelsey, Karl

AU - McClean, Michael

AU - Gillison, Maura

AU - Boccia, Stefania

AU - Hashibe, Mia

AU - Amy Lee, Yuan Chin

AU - Boffetta, Paolo

N1 - Funding Information: The pooled data coordination team were supported by National Cancer Institute grant R03CA113157and by National Institute of Dental and Craniofacial Research grantR03DE016611. The IARC Multicenter study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [FIS 97/ 0024, FIS 97/0662, BAE 01/5013], International Union Against Cancer (UICC), and Yamagiwa-Yoshida Memorial International Cancer Study Grant. The Seattle study was funded by NIH [R01CA048996,R01DE012609]. The Iowa study was funded by NIH [NIDCRR01DE011979, NIDCRR01DE013110, NIH FIRCATW001500] and Veterans Affairs Merit Review Funds. The Boston study was funded by NIH [R01CA078609, R01CA100679]. The Baltimore study was funded by NIH [DE016631]. Funding Information: The pooled data coordination team were supported by National Cancer Institute grant R03CA113157 and by National Institute of Dental and Craniofacial Research grant R03DE016611 . The IARC Multicenter study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [ FIS 97/ 0024 , FIS 97/0662 , BAE 01/5013 ], International Union Against Cancer (UICC) , and Yamagiwa-Yoshida Memorial International Cancer Study Grant. The Seattle study was funded by NIH [ R01CA048996 , R01DE012609 ]. The Iowa study was funded by NIH [NIDCR R01DE011979, NIDCR R01DE013110 , NIH FIRCA TW001500 ] and Veterans Affairs Merit Review Funds . The Boston study was funded by NIH [ R01CA078609 , R01CA100679 ]. The Baltimore study was funded by NIH [ DE016631 ]. Publisher Copyright: © 2021 Elsevier Ltd

PY - 2021/12

Y1 - 2021/12

N2 - Background: The aim of this study was to investigate the relationship between high-risk genotypes of Human Papilloma Virus (HPV) and cancer of different subsites of the oral cavity. Material and methods: A pooled analysis of five studies included on the International Head and Neck Cancer Epidemiology (INHANCE) Consortium was conducted. HPV 16 and HPV 18 were considered. Adjusted odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for HPV and each oral cavity subsites were simultaneously estimated using multinomial logistic regression models. Results: The analysis included 1157 cases and 3272 controls. This study showed a slightly higher prevalence of HPV infection among oral cancer cases than controls. In particular, an increased risk of other and not otherwise specified (NOS) sites within the oral cavity, oral tongue, palate and floor of mouth cancer was observed for overall HPV16 positivity (OR = 1.66, 95 % CI: 1.01−2.72; OR = 1.97, 95 % CI: 1.36−2.85; OR = 2.48, 95 % CI: 1.50−4.11; OR = 2.71, 95 % CI: 1.06−6.95, respectively). In particular, HPV16E7 was related to cancer of floor of mouth, oral cavity NOS and palate (OR = 2.71, 95 % CI: 1.06−6.95; OR = 3.32, 95 % CI:1.53−7.19; OR = 3.34, 95 % CI:1.38−8.06). Results were inconsistent for HPV18 due to low prevalence of infection. Conclusion: Our study suggests that HPV16 infection may increase the risk of developing floor of mouth, gum, tongue, and palate cancers. Clinical relevance: Subjects with HPV infection have a higher risk of cancer from all sites of the oral cavity.

AB - Background: The aim of this study was to investigate the relationship between high-risk genotypes of Human Papilloma Virus (HPV) and cancer of different subsites of the oral cavity. Material and methods: A pooled analysis of five studies included on the International Head and Neck Cancer Epidemiology (INHANCE) Consortium was conducted. HPV 16 and HPV 18 were considered. Adjusted odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for HPV and each oral cavity subsites were simultaneously estimated using multinomial logistic regression models. Results: The analysis included 1157 cases and 3272 controls. This study showed a slightly higher prevalence of HPV infection among oral cancer cases than controls. In particular, an increased risk of other and not otherwise specified (NOS) sites within the oral cavity, oral tongue, palate and floor of mouth cancer was observed for overall HPV16 positivity (OR = 1.66, 95 % CI: 1.01−2.72; OR = 1.97, 95 % CI: 1.36−2.85; OR = 2.48, 95 % CI: 1.50−4.11; OR = 2.71, 95 % CI: 1.06−6.95, respectively). In particular, HPV16E7 was related to cancer of floor of mouth, oral cavity NOS and palate (OR = 2.71, 95 % CI: 1.06−6.95; OR = 3.32, 95 % CI:1.53−7.19; OR = 3.34, 95 % CI:1.38−8.06). Results were inconsistent for HPV18 due to low prevalence of infection. Conclusion: Our study suggests that HPV16 infection may increase the risk of developing floor of mouth, gum, tongue, and palate cancers. Clinical relevance: Subjects with HPV infection have a higher risk of cancer from all sites of the oral cavity.

KW - Floor of mouth

KW - Gum

KW - Human papilloma virus

KW - Oral cancer

KW - Oral cavity

KW - Palate

KW - Tongue

UR - http://www.scopus.com/inward/record.url?scp=85114674241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114674241&partnerID=8YFLogxK

U2 - 10.1016/j.canep.2021.102020

DO - 10.1016/j.canep.2021.102020

M3 - Article

C2 - 34509873

AN - SCOPUS:85114674241

SN - 1877-7821

VL - 75

JO - Cancer Epidemiology

JF - Cancer Epidemiology

M1 - 102020

ER -

Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this